Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission
Daiichi Sankyo
Boehringer Ingelheim
Argus Health

Generated: January 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021790

« Back to Dashboard

NDA 021790 describes DACOGEN, which is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the DACOGEN profile page.

The generic ingredient in DACOGEN is decitabine. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the decitabine profile page.
Summary for 021790
Applicant:Otsuka Pharm Co Ltd
Formulation / Manufacturing:see details
Pharmacology for NDA: 021790
Suppliers and Packaging for NDA: 021790
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DACOGEN decitabine INJECTABLE;INTRAVENOUS 021790 NDA Otsuka America Pharmaceutical, Inc. 59148-046 59148-046-70 1 VIAL in 1 CARTON (59148-046-70) > 20 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength50MG/VIAL
Approval Date:May 2, 2006TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.